10
Nov

Fran Zipp, Lachman Consultants’ CEO to Deliver Opening Address at 2020 ISPE Singapore Virtual Conference

(Westbury, NY— November 2020) Fran Zipp, Past International Board Chair, ISPE and CEO of Lachman Consultants is scheduled to deliver opening remarks at the 2020 ISPE Singapore Affiliate Conference & Exhibition. The three-day virtual event featuring programs, seminars, leading-edge technology, and presentations by top industry experts will take place Wednesday, December 9th through Friday, December […]

Read More
08
Oct

Lachman Consultants Attendance at ISPE 2020 Virtual Meeting & Expo to Feature Innovative Consultant Services

(Westbury, NY – October 2020) Lachman Consultants Services, Inc. (Lachman Consultants), a provider of compliance, regulatory, and technical consulting services to the global pharmaceutical and related industries, has announced that it will be an active participant at the 2020 ISPE Annual Meeting and Expo, Monday, November 2nd  through Friday, November 6th, 2020. Entitled “Driving the […]

Read More
05
Oct
Person wearing VR gear

Lachman Consultants Launches 3-D Virtual Inspections for Life Science Clients

New Technology Resolves On-Site Inspection Challenges Amid Pandemic (Westbury, NY – October 2020) Lachman Consultants Services, Inc. (Lachman Consultants) is introducing Virtual Touring, a state-of-the-art experience that allows manufacturing facilities to safely conduct virtual inspections, tours and visits, even in the midst of the COVID-19 pandemic. This technology is vital to the Life Sciences industry, […]

Read More
30
Sep

Ensuring Manufacturing Continuity for Essential Medicines

John Darby, M.Sc., Senior Director of Lachman Consultants, wrote a recent article for Contract Pharma applying the principles of Quality Risk Management to get medicines to market faster. Here is a brief excerpt from the article: “As vaccine development progresses globally to address the coronavirus pandemic, assurance of manufacturing capability to address supply needs is […]

Read More
29
Sep

Fran Zipp to Participate in Women in Leadership Forum at CPhI festival of pharma

After 30 years of being a major global pharmaceutical event uniting buyers and suppliers of fine pharmaceutical chemicals, CPhI in 2020 is moving to a virtual event. This year, CPhI festival of pharma will be held October 5-16, 2020. Fran Zipp, CEO and President, Lachman Consultants, will be participating in the Women in Leadership Forum, being held on Tuesday […]

Read More
14
Sep

Lachman OnCall™ GMP Teleconsulting – When you can’t wait to get going.

When you can’t wait for answers to your GMP questions, it’s time for Lachman OnCall™. Our Subject Matter Experts (SMEs) understand you need advice right away. Lachman’s SMEs have the knowledge, experience, and skills to address your most urgent scientific, technology, and compliance-related questions, such as: “We had to shut down our sterile manufacturing plant […]

Read More
08
Sep

Ricki Chase, Executive Director, Compliance, to Present Webinar on FDA Regulations and Inspections Amid COVID-19

Ricki Chase, Executive Director, Compliance, will be presenting a webinar “FDA Regulations and Inspections Amid COVID-19” as part of the Contract Pharma 2020 Contracting and Outsourcing Conference. Her presentation will be on September 30, 2020, 1 PM EST. Please register at this link. The entire agenda and registration for other talks in the series, which […]

Read More
25
Aug

Lachman Consultants Participates in Webinar with Arnold & Porter on DSCSA

Earlier this month, Ricki Chase, Executive Director, participated as a presenter in the webinar “Drug Supply Chain Security Act: Legal Overview and Cross-Enterprise Compliance Strategies” in collaboration with Howard Sklamberg (Partner) and Abraham Gitterman (Senior Associate) of Arnold & Porter. In this webinar, the following was covered: The basics of the Drug Supply Chain Security […]

Read More
04
Aug

Webinar: Drug Supply Chain Security Act: Legal Overview and Cross-Enterprise Compliance Strategies (August 11, 2020 @1:00-2:00 PM ET)

In 2019, FDA issued the first Warning Letter for violations of the Drug Supply Chain Security Act, signaling its heightened attention to supply chain and distribution issues. Since DSCSA was enacted in 2013, various provision have come into effect. It is important for companies not just to understand the law’s requirements, but also how to […]

Read More
17
Jul

Mary Oates to Participate in Webinar on Virtual Inspections

On Tuesday, July 21, Mary Oates, Ph.D., Vice President, Compliance Services, will be participating in a webinar organized by Informa, publishers of the Pink Sheet and Scrip. Mary will be a panelist in a session on Virtual Drug Inspections, occurring at 2 PM EST. The entire webinar series, which is taking place over a 24 […]

Read More
1 2 3